Literature DB >> 22434000

Historic emergence, impact and current status of shrimp pathogens in the Americas.

D V Lightner1, R M Redman, C R Pantoja, K F J Tang, B L Noble, P Schofield, L L Mohney, L M Nunan, S A Navarro.   

Abstract

Shrimp farming in the Americas began to develop in the late 1970s into a significant industry. In its first decade of development, the technology used was simple and postlarvae (PLs) produced from wild adults and wild caught PLs were used for stocking farms. Prior to 1990, there were no World Animal Health Organization (OIE) listed diseases, but that changed rapidly commensurate with the phenomenal growth of the global shrimp farming industry. There was relatively little international trade of live or frozen commodity shrimp between Asia and the Americas in those early years, and with a few exceptions, most of the diseases known before 1980 were due to disease agents that were opportunistic or part of the shrimps' local environment. Tetrahedral baculovirosis, caused by Baculovirus penaei (BP), and necrotizing hepatopancreatitis (NHP) and its bacterial agent Hepatobacterium penaei, were among the "American" diseases that eventually became OIE listed and have not become established outside of the Americas. As the industry grew after 1980, a number of new diseases that soon became OIE listed, emerged in the Americas or were introduced from Asia. Spherical baculovirus, caused by MBV, although discovered in the Americas in imported live Penaeus monodon, was subsequently found to be common in wild and farmed Asian, Australian and African penaeids. Infectious hypodermal and hematopoietic necrosis virus (IHHNV) was introduced from the Philippines in the mid 1970s with live P. monodon and was eventually found throughout the Americas and subsequently in much of the shrimp farming industry in the eastern hemisphere. Taura syndrome emerged in Penaeus vannamei farms in 1991-1992 in Ecuador and was transferred to SE Asia with live shrimp by 1999 where it also caused severe losses. White Spot Disease (WSD) caused by White spot syndrome virus (WSSV) emerged in East Asia in ∼1992, and spread throughout most of the Asian shrimp farming industry by 1994. By 1995, WSSV reached the eastern USA via frozen commodity products and it reached the main shrimp farming countries of the Americas located on the Pacific side of the continents by the same mechanism in 1999. As is the case in Asia, WSD is the dominant disease problem of farmed shrimp in the Americas. The most recent disease to emerge in the Americas was infectious myonecrosis caused by IMN virus. As had happened before, within 3years of its discovery, the disease had been transferred to SE Asia with live P. vannamei, and because of its impact on the industry and potential for further spread in was listed by the OIE in 2005. Despite the huge negative impact of disease on the shrimp farming industry in the Americas, the industry has continued to grow and mature into a more sustainable industry. In marked contrast to 15-20years ago when PLs produced from wild adults and wild PLs were used to stock farms in the Americas, the industry now relies on domesticated lines of broodstock that have undergone selection for desirable characteristics including disease resistance.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22434000     DOI: 10.1016/j.jip.2012.03.006

Source DB:  PubMed          Journal:  J Invertebr Pathol        ISSN: 0022-2011            Impact factor:   2.841


  32 in total

1.  Crustacean Genome Exploration Reveals the Evolutionary Origin of White Spot Syndrome Virus.

Authors:  Satoshi Kawato; Aiko Shitara; Yuanyuan Wang; Reiko Nozaki; Hidehiro Kondo; Ikuo Hirono
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Vulnerability of coastal livelihoods to shrimp farming: Insights from Mozambique.

Authors:  Jessica Blythe; Mark Flaherty; Grant Murray
Journal:  Ambio       Date:  2014-11-13       Impact factor: 5.129

3.  Antiviral Activity of Ctn[15-34], A Cathelicidin-Derived Eicosapeptide, Against Infectious Myonecrosis Virus in Litopenaeus vannamei Primary Hemocyte Cultures.

Authors:  P R N Vieira-Girão; C B Falcão; I R C B Rocha; H M R Lucena; F H F Costa; G Rádis-Baptista
Journal:  Food Environ Virol       Date:  2017-02-16       Impact factor: 2.778

4.  Taura syndrome virus IRES initiates translation by binding its tRNA-mRNA-like structural element in the ribosomal decoding center.

Authors:  Cha San Koh; Axel F Brilot; Nikolaus Grigorieff; Andrei A Korostelev
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-09       Impact factor: 11.205

5.  Small creatures use small RNAs to direct antiviral defenses.

Authors:  Leah R Sabin; Sara Cherry
Journal:  Eur J Immunol       Date:  2013-01       Impact factor: 5.532

6.  Identification of antigenic domains and peptides from VP15 of white spot syndrome virus and their antiviral effects in Marsupenaeus japonicus.

Authors:  Jirayu Boonyakida; Jian Xu; Jun Satoh; Takafumi Nakanishi; Tohru Mekata; Tatsuya Kato; Enoch Y Park
Journal:  Sci Rep       Date:  2021-06-17       Impact factor: 4.379

Review 7.  Viral Shrimp Diseases Listed by the OIE: A Review.

Authors:  Dain Lee; Young-Bin Yu; Jae-Ho Choi; A-Hyun Jo; Su-Min Hong; Ju-Chan Kang; Jun-Hwan Kim
Journal:  Viruses       Date:  2022-03-12       Impact factor: 5.048

8.  Genetic improvement of Pacific white shrimp [Penaeus (Litopenaeus) vannamei]: perspectives for genomic selection.

Authors:  Héctor Castillo-Juárez; Gabriel R Campos-Montes; Alejandra Caballero-Zamora; Hugo H Montaldo
Journal:  Front Genet       Date:  2015-03-24       Impact factor: 4.599

9.  Rapid detection of shrimp white spot syndrome virus by real time, isothermal recombinase polymerase amplification assay.

Authors:  Xiaoming Xia; Yongxin Yu; Manfred Weidmann; Yingjie Pan; Shuling Yan; Yongjie Wang
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

10.  Development of duplex real-time PCR for the detection of WSSV and PstDV1 in cultivated shrimp.

Authors:  Carlos A G Leal; Alex F Carvalho; Rômulo C Leite; Henrique C P Figueiredo
Journal:  BMC Vet Res       Date:  2014-07-05       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.